Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.11 $1.92 Thursday, 9th May 2024 OCGN stock ended at $1.67. This is 2.91% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 6.19% from a day low at $1.62 to a day high of $1.72.
90 days $0.525 $2.10
52 weeks $0.345 $2.10

Historical Ocugen Inc prices

Date Open High Low Close Volume
Feb 28, 2024 $1.01 $1.02 $0.91 $0.94 6 083 198
Feb 27, 2024 $0.92 $1.00 $0.87 $0.99 9 521 575
Feb 26, 2024 $0.85 $0.99 $0.84 $0.90 13 218 879
Feb 23, 2024 $0.95 $0.96 $0.743 $0.795 16 628 142
Feb 22, 2024 $1.15 $1.15 $0.91 $1.00 14 861 246
Feb 21, 2024 $1.15 $1.15 $0.90 $1.06 26 322 814
Feb 20, 2024 $1.26 $1.28 $1.00 $1.04 39 881 894
Feb 16, 2024 $0.760 $0.98 $0.760 $0.95 19 525 443
Feb 15, 2024 $0.705 $0.755 $0.685 $0.746 7 563 266
Feb 14, 2024 $0.610 $0.690 $0.610 $0.667 5 020 127
Feb 13, 2024 $0.630 $0.631 $0.590 $0.610 2 168 328
Feb 12, 2024 $0.550 $0.650 $0.550 $0.634 6 363 181
Feb 09, 2024 $0.530 $0.542 $0.525 $0.538 1 140 267
Feb 08, 2024 $0.525 $0.535 $0.520 $0.520 1 457 005
Feb 07, 2024 $0.513 $0.531 $0.500 $0.530 1 347 733
Feb 06, 2024 $0.520 $0.530 $0.506 $0.522 1 305 460
Feb 05, 2024 $0.519 $0.523 $0.495 $0.504 1 260 259
Feb 02, 2024 $0.530 $0.554 $0.507 $0.528 1 120 039
Feb 01, 2024 $0.534 $0.550 $0.530 $0.530 1 071 870
Jan 31, 2024 $0.554 $0.568 $0.535 $0.536 1 391 571
Jan 30, 2024 $0.572 $0.574 $0.540 $0.551 1 137 244
Jan 29, 2024 $0.550 $0.574 $0.533 $0.566 1 328 849
Jan 26, 2024 $0.580 $0.580 $0.541 $0.541 1 294 848
Jan 25, 2024 $0.550 $0.583 $0.548 $0.575 1 836 166
Jan 24, 2024 $0.560 $0.573 $0.546 $0.546 2 754 760
Click to get the best stock tips daily for free!

About Ocugen Inc

Ocugen Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related ... OCGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT